29th Sep 2005 07:00
Cyprotex PLC29 September 2005 Press Release 29 September 2005 Cyprotex Plc ("Cyprotex" or "the Company") Issue of 71,766 shares pursuant exercise of options Cyprotex PLC (AIM: CRX), the drug discovery technology and information company,today announces that it has issued 71,766 new ordinary shares of 0.1p each ("newOrdinary Shares") pursuant to the exercise of options. The issue of the new Ordinary Shares is subject to the new Ordinary Shares beingadmitted to trading on AIM, application for which has been made. Trading in thenew Ordinary Shares, which will rank pari passu in all respects with theexisting ordinary shares, is expected to commence on 30th September, 2005. - Ends - For further information:Cyprotex PLCRobert Morrisson Atwater, Tel: +44 (0) 1625 505 152Chairman & Chief Executive [email protected] www.cyprotex.com Code SecuritiesCharles Walker Tel: +44 (0) 20 7776 [email protected] www.codesecurities.com Media enquiries:Abchurch CommunicationsHeather Salmond / Samantha Robbins Tel: +44 (0) 20 7398 [email protected] www.abchurch-group.com This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
CRX.L